Investing in classic cars: Collectors talk about what they buy — and why
Classic car values continue to rise, turning what was once a hobby into a profitable asset class, reports CNBC’s Monica Pitrelli.
Huawei forecasts 9% revenue growth in 2023 as smartphone sales surge
Chinese tech giant Huawei Technologies expects to report revenue exceeding 700 billion yuan for 2023.
Baidu says its ChatGPT rival Ernie bot now has more than 100 million users
Baidu did not specify whether the user numbers were active or for a specific time period. OpenAI said in November that ChatGPT had about 100 million weekly active users.
Asia markets wrap up last trading day of 2023 with small declines; China stocks inch higher as tech firms continue to rise
Asia-Pacific markets fell on the last trading day of 2023, with China stocks being the sole exception as the country’s tech companies continued their advance.
This is 2023’s best-performing market in Asia — how will it fare in the new year?
Japan is Asia’s best-performing market for 2023, with the Nikkei 225 advancing 28% to hit levels not seen since 1989.
S&P 500 falls slightly Friday, but rides 9-week win streak to end 2023 with 24% gain: Live updates
Stocks fell slightly on Friday, but the S&P 500 closed out 2023 with a surprising gain of 24%.
Fake reviews are a multibillion-dollar quicksand — here’s how to avoid getting sucked in
For many, a string of glowing reviews, or the mark of five golden stars, usually seals the deal in a purchase decision. But what’s real and what’s phony?
CNBC Daily Open: For the S&P, the last mile’s the longest
The S&P 500’s tantalizingly close to an all-time high. The index added 0.04% yesterday to close at 4,783.35, just about 10 points away from its record close.
Fund managers turn cautious on European stocks, BofA survey shows — here’s why
Fund managers strike a cautious tone on the prospects of the European economy — and stock market — going into 2024, but see some opportunities.
Piper Sandler reveals its top 3 biotech stock picks for 2024 — and gives one 90% upside
“After another difficult year, there are signs that biotech is recovering into 2024,” the investment bank says, citing the prospect of interest rate cuts.
